Tengpeng Hu
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.
Journal: Acta dermato-venereologica
Published: June 20, 2020
The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma.
Journal: Dermatology (Basel, Switzerland)
Published: January 31, 2020
Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.
Journal: Oncotarget
Published: March 11, 2019
Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
Journal: Dermatology (Basel, Switzerland)
Published: January 23, 2019
SATB1 in Malignant T Cells.
Journal: The Journal of investigative dermatology
Published: November 23, 2017
STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Journal: Oncotarget
Published: March 23, 2016
B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
Journal: Leukemia
Published: June 13, 2014
Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Journal: Oncology reports
Published: February 21, 2014
Last Updated: 09/26/2026